Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Behind the Scenes with Eppendorf

Published: Tuesday, October 09, 2012
Last Updated: Tuesday, October 09, 2012
Bookmark and Share
New video provides unique insight into manufacturing and production of consumables.

Eppendorf is providing an exclusive behind the scenes video look at the production of consumables and providing insight into the company’s exceptional quality control throughout the whole manufacturing process.

The new video, available on the company’s website, demonstrates Eppendorf’s commitment to delivering consistently high quality and reliable consumables for the laboratory.

Take a tour at www.eppendorf.com/consumables or bit.ly/Eppendorfconsumablesvideo.

Dr. Sirkka Scheeff, Product Manager Consumables at Eppendorf, said, “As a consumables manufacturer we provide a high level of transparency into the production process. It clearly shows how we understand every stage, taking the utmost care in ensuring that only the highest quality products are manufactured. As a result of our stringent quality control procedures, our consumables are reliable and robust, reducing the risk of experiment failure, scrappage and lost time”.

Eppendorf’s knowledge and decades of experience are apparent through every step of the process, from selecting the highest quality raw materials to testing the final product.

A prime example is shown in scenes of the complex fully automated production process undertaken in Class 6 cleanroom conditions and the continuous strict internal and external procedures that ensure absolute precision product quality.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More than 4,900+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Philipp von Loeper to be New Chairman of the Supervisory Board of Eppendorf AG
Klaus Fink resigns as Chairman after five years
Wednesday, June 08, 2016
Eppendorf Continues Successful Development
Group sales of €629.1 million (18.5% growth in sales).
Tuesday, May 03, 2016
Scientific News
Breakthrough Flu Vaccine Inhibited by Pre-existing Antibodies
Universal truths – how existing antibodies are sabotaging the most promising new human flu vaccines.
Zika Vaccine Candidates Show Promise
Two experimental vaccines have shown promise against a major viral strain responsible for the Brazilian Zika outbreak.
NIH Begins Yellow Fever Vaccine Trial
NIH has initiated an early-stage clinical trial of a vaccine to protect against yellow fever.
Antibody Drug Shows Promise in HIV Treatment
Researchers are a step closer to an alternative HIV treatment that has the potential for lasting effects and less frequent dosing.
Flu Vaccine May Reduce Risk of Death For Type 2 Diabetes Patients
Researchers at Imperial College London have suggested that the vaccine may have substantial benefits for patients with long-term conditions.
Flu Vaccine May Reduce Death Risk of Type 2 Diabetes
New research suggests that a new flu vaccine may reduce probability of type 2 diabetes patients being hospitalised with stroke and heart failure.
Disrupting Tumour-Promotion in Humans
Researchers have modified an existing protein to represses a specific cancer-promoting ‘message’ within cells.
Protein Nanocages Could Improve Drug Design and Delivery
HHMI scientists have designed and built 10 large protein icosahedra that are similar to viral capsids that carry viral DNA.
Vaccine Strategy Targets Multiple Influenza Viruses
Scientists have identified vaccine-induced antibodies that can neutralize strains of influenza virus that infect humans.
Antibody-Based Drug for Multiple Sclerosis
New antibody-based drug paves the way for new strategies for controlling and treating multiple sclerosis.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!